Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio

被引:119
作者
Aman, MG [1 ]
Lam, KSL [1 ]
Collier-Crespin, A [1 ]
机构
[1] Ohio State Univ, Nisonger Ctr Mental Retardat & Dev Disabil, Columbus, OH 43210 USA
关键词
AED; psychotropic drugs; antileptic drugs; Autism;
D O I
10.1023/A:1025883612879
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
To date, there have been few surveys of psychotropic and antiepileptic drug (AED) prevalence in individuals with autism-spectrum conditions. We surveyed 747 families in the Autism Society of Ohio regarding the use of psychotropic drugs, AEDs, and over-the-counter (OTC) preparations for autism. In all, 417 families (55.8%) replied. A total of 45.6% were taking some form of psychotropic agent (including St. John's wort and melatonin), whereas 11.5% were taking AEDs, and 10.3% took OTC autism preparations. The most common psychotropic agents included antidepressants (21.6%), antipsychotics (14.9%), antihypertensives (12.5%), and stimulants (11.3%). Some 51.6% were prescribed psychotropic drugs or AEDs, and 55.4% took psychotropic drugs, AEDs, or autism supplements. Demographic variables frequently found to be associated with medication use included greater age, more severe autism, more severe intellectual handicap, and housing outside the family home. Whereas there is empirical support for the use of some of these psychotropic agents in autism, others are being prescribed with minimal research support. OTC autism preparations were used in substantial numbers of individuals, despite limited research support and the possibility of toxic effects.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 25 条
[1]  
Aman MG, 1999, MENT RETARD DEV D R, V5, P279, DOI 10.1002/(SICI)1098-2779(1999)5:4<279::AID-MRDD5>3.0.CO
[2]  
2-6
[3]   PSYCHOTROPIC AND ANTICONVULSANT DRUGS IN SUBJECTS WITH AUTISM - PREVALENCE AND PATTERNS OF USE [J].
AMAN, MG ;
VANBOURGONDIEN, ME ;
WOLFORD, PL ;
SARPHARE, G .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1995, 34 (12) :1672-1681
[5]  
AMAN MG, 1995, AM J MENT RETARD, V99, P500
[6]  
Aman MG, 1999, MENT RETARD DEV D R, V5, P253, DOI 10.1002/(SICI)1098-2779(1999)5:4<253::AID-MRDD2>3.3.CO
[7]  
2-I
[8]   Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders [J].
Aman, MG ;
Langworthy, KS .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2000, 30 (05) :451-459
[9]  
[Anonymous], 1982, CASE CONTROL STUDIES
[10]  
BATES WJ, 1986, AM J MENT RETARD, V90, P363